Truist Financial Increases Omega Healthcare Investors (NYSE:OHI) Price Target to $33.00

Omega Healthcare Investors (NYSE:OHI) had its price objective lifted by Truist Financial from $32.00 to $33.00 in a research note issued to investors on Wednesday, Benzinga reports. They currently have a hold rating on the real estate investment trust’s stock.

Other equities research analysts have also issued research reports about the stock. Citigroup raised shares of Omega Healthcare Investors from a neutral rating to a buy rating and upped their price target for the company from $32.00 to $35.00 in a research report on Friday, March 22nd. Wells Fargo & Company raised shares of Omega Healthcare Investors to a strong-buy rating in a report on Friday, June 14th. Finally, JMP Securities reissued a market perform rating on shares of Omega Healthcare Investors in a report on Monday, May 6th. Eight investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Omega Healthcare Investors currently has an average rating of Moderate Buy and an average price target of $33.71.

Omega Healthcare Investors Price Performance

NYSE OHI opened at $34.25 on Wednesday. Omega Healthcare Investors has a 52 week low of $27.53 and a 52 week high of $34.77. The firm has a market capitalization of $8.46 billion, a P/E ratio of 30.86, a PEG ratio of 1.22 and a beta of 0.96. The company has a quick ratio of 6.68, a current ratio of 6.68 and a debt-to-equity ratio of 1.36. The company has a 50-day moving average price of $31.69 and a 200-day moving average price of $30.97.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Tuesday, April 30th were paid a $0.67 dividend. The ex-dividend date of this dividend was Monday, April 29th. This represents a $2.68 annualized dividend and a yield of 7.82%. Omega Healthcare Investors’s payout ratio is 241.44%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of Omega Healthcare Investors by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust’s stock valued at $1,120,478,000 after acquiring an additional 165,105 shares during the last quarter. Centersquare Investment Management LLC boosted its position in shares of Omega Healthcare Investors by 36.6% during the 4th quarter. Centersquare Investment Management LLC now owns 3,585,255 shares of the real estate investment trust’s stock valued at $109,924,000 after acquiring an additional 960,997 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Omega Healthcare Investors by 1.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,501,495 shares of the real estate investment trust’s stock valued at $107,358,000 after buying an additional 40,999 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Omega Healthcare Investors by 4.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,948,554 shares of the real estate investment trust’s stock valued at $90,403,000 after buying an additional 124,483 shares during the period. Finally, Norges Bank purchased a new stake in Omega Healthcare Investors during the 4th quarter valued at $61,698,000. 65.25% of the stock is currently owned by institutional investors.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.